IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 81 - 100 of 1096 stories.
February 20, 2014
Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The Simon Sturge...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-appoints-Simon-Sturge-as-new-head-of-biosimilars-unit_58935.html
February 19, 2014
Excipact says that Saudi Kayan Petrochemical (Al Jubail), an affiliate of Sabic, has received an Excipact certification from SGS, one of its certification bodies. The Excipact...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Saudi-Kayan-gets-Excipact-certification-as-pharmaceutical-excipient-supplier_58893.html
February 18, 2014
Aurobindo Pharma reports rise in API sales The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-18-February-2014_58865.html
February 17, 2014
Novartis announced today that it is buying CoStim Pharmaceuticals (Cambridge, MA), a privately held biotechnology company focused on harnessing the immune system to eliminate...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novartis-to-acquire-biotech-company-CoStim-Pharmaceuticals_58852.html
February 12, 2014
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI), a contract development and manufacturing organization specializing in small molecule active pharmaceutical ingredients (APIs), says...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-firm-Cedarburg-Hauser-appoints-director-of-process-development_58771.html
February 12, 2014
The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-Pharma-reports-rise-in-API-sales_58768.html
February 11, 2014
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-business-of-Dr-Reddys-reports-fall-in-sales_58734.html
February 11, 2014
Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-fall-in-profits_58732.html
February 11, 2014
Jazz Pharmaceuticals (Dublin), a specialty biopharmaceutical company, on Monday held a ground breaking ceremony for a €45–50 million ($60-68 million) manufacturing and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Jazz-Pharmaceuticals-builds-$60-million-manufacturing-and-development-plant-in-Ireland_58731.html
February 11, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-11-February-2014_58730.html
February 7, 2014
The active pharmaceutical ingredient (API) business of Ranbaxy Laboratories (Gurgaon, India) reports sales of 1.37 billion Indian rupees ($22 million) in the fourth quarter of 2013...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ranbaxys-API-sales-fall-on-lower-demand_58659.html
February 7, 2014
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tevas-API-business-reports-fall-in-sales_58658.html
February 5, 2014
FMC today reported fourth-quarter earnings down 73.5% year-on-year (YOY), to $27.1 million, or 20 cts/share, on sales up 24%, to $1.1 billion. Earnings were hit by $114.3 million in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FMC-earnings-beat-estimates-as-ag-results-jump_58582.html
February 4, 2014
Johnson Matthey appoints new CEO, fine chemicals sales up Johnson Matthey announced the appointment of its new CEO and reported the third-quarter results, covering 1 October 2013...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-4-February-2014_58536.html
January 28, 2014
Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-earnings-fall-YOY-but-beat-estimates_58379.html
January 28, 2014
Informex 2014: Rising certainty despite challenges for pharma Attendees and exhibitors at this year's Informex USA, held last week in Miami Beach, were mostly optimistic about the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-28-January-2014_58352.html
January 24, 2014
The US Food and Drug Administration (FDA) announced on 23 January that it has notified Ranbaxy Laboratories (Gurgaon, India), that it is prohibited from manufacturing and distributing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-prohibits-Ranbaxy-API-plant-from-producing-and-distributing-products-for-US-market_58291.html
January 23, 2014
Attendees and exhibitors at this year's Informex USA, held this week in Miami Beach, were mostly optimistic about the direction of the fine chemicals and contract manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2014-Rising-certainty-despite-challenges-for-pharma_58279.html
January 23, 2014
Lonza recorded a 44.2% fall in profits for 2013 compared with 2012, to 87 million Swiss francs ($95.7 million). Sales for 2013 decreased by 4.2%, to SF3.58 billion, due to lower sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-reports-fall-in-profits-sales_58208.html
Pages: « Previous  1 2 3 4 [5] 6 7 8 9 10 11 12 13 14 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa